Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2040 of 6351
-
Could a lower warfarin dose cut bleeding risk in valve patients?
Disease control Recruiting nowThis study evaluates the use of a lower INR target (1.5 to 2.5) in patients with a mechanical bileaflet heart valve in the aortic position. This study will inform physicians about whether a lower INR target will decrease the risk of bleeding or increase the risk of blood clot for…
Phase 3 • Sponsor: Population Health Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New hope for ulcerative colitis: extended trial tests Long-Term relief
Disease control OngoingThe purpose of this open-label extension (OLE) study is to evaluate the safety and efficacy of etrasimod in participants with moderately to severely active ulcerative colitis (UC) who previously received double-blind treatment (either etrasimod 2 mg per day or placebo) during par…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New combo therapy shows promise for Hard-to-Treat cancers
Disease control OngoingThe primary purpose of the study is to evaluate safety and tolerability of E7389 liposomal formulation (E7389-LF) in combination with nivolumab and to determine the recommended Phase 2 dose (RP2D) in Phase 1b part and to evaluate objective response rate (ORR) of E7389-LF and nivo…
Phase 1/2 • Sponsor: Eisai Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Can brain tests unlock the social struggles of turner syndrome?
Knowledge-focused CompletedTurner syndrome (TS) is a rare chromosomal disorder characterized by partial or complete loss of one of the X chromosomes that affects about one in every 2000 female babies born. These young patients described difficulties making friends, understanding others' emotions and intent…
Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Surgery or strength? new study pits hip replacement against exercise for arthritis pain
Disease control OngoingHip osteoarthritis is associated with joint pain, physical disability, decreased muscle strength and poor health status, and the most common cause for total hip arthroplasty. No studies have investigated the effect of total hip arthroplasty compared to non-surgical treatment in p…
Sponsor: Vejle Hospital • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Scientists dive deep into kidney tissue to unlock secrets of disease
Knowledge-focused Recruiting nowAcute kidney injury (AKI) and chronic kidney disease (CKD) impose a significant global health burden. Yet, no effective therapies currently exist for AKI, and only a few are available for CKD. Despite significant effort from industry and academia, development of pharmacologic th…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Could a sleep machine boost stroke recovery?
Disease control Recruiting nowThe proposed study is a randomized controlled trial among an anicipated 180 participants with acute ischemic stroke and mod/severe OSA diagnosed by ambulatory polysomnography (PSG) comparing PAP treatment with usual care concerning the primary outcome of functional recovery.
Sponsor: Yale University • Aim: Disease control
Last updated Jun 26, 2026 13:36 UTC
-
Smart insulin systems may shield hearts in type 1 diabetes
Disease control OngoingThis is a prospective, non-randomized, observational cohort study conducted in adult patients with type 1 diabetes.Participants with poorly controlled T1D under multiple daily injection (MDI) treatment will be assigned to one of three treatment groups: 1. hybrid closed-loop syst…
Sponsor: Attikon Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Promising combo for lymphoma hits early snag – trial stopped
Disease control Stopped earlyThis research is being done to assess Umbralisib and Rituximab as a first line therapy for Follicular Lymphoma or Marginal Zone Lymphoma.
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could a simple hormone shot improve IVF live birth rates?
Disease control Recruiting nowThe objectives of this study are to compare the efficacy of the dual trigger group vs the hCG trigger group on the live birth rate in women undergoing IVF and the efficacy of the agonist in LP group vs the placebo group on the live birth rate in women undergoing FET.
Phase 3 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can a quick workout before lunch curb teen appetite?
Disease control CompletedThe aim of the present study is to compare the effect of realizing an exercise right before or right after a meal of on energy intake, appetite feelings and food reward in adolescents with obesity.
Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Immunotherapy drug shows promise for tough colorectal cancer
Disease control CompletedAn open-label, single-arm, phase II, multicentre clinical trial to determine the rate of durable clinical benefit of nivolumab in patients with class II expressing microsatellite stable colorectal cancer.
Phase 2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a cancer drug slow down a rare leukemia?
Disease control OngoingThis study is to find out if treating Chronic Myelomonocytic Leukemia (CMML) with a study drug (ruxolitinib) can improve outcomes of patients with CMML.
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can a Low-Cost portable simulator retrain driving skills in neurological conditions?
Symptom relief CompletedThe use of simulators to retrain driving skills of patients with stroke, Parkinson's disease (PD), or multiple sclerosis (MS) is very limited because of cost, space required, and incidence of simulator sickness in high fidelity simulators. The Principal investigator recently deve…
Sponsor: University of Kansas Medical Center • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Promising combo for advanced melanoma trial halted early
Disease control Stopped earlyThe study aims to evaluate the safety and preliminary efficacy of the combination of cabozantinib and pembrolizumab in advanced melanoma
Phase 1/2 • Sponsor: John Rieth • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New light treatment offers hope for rare vulvar cancer
Disease control Recruiting nowVulvar Paget's disease is a rare skin tumour which affect Caucasian post-menopausal women. The disease is revealed by erythematous, eczematous, pruritus and vulvar burns. The diagnosis is often late (from a few months to several years) because the symptoms are neglected by patien…
Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can a nerve stimulator turn down the fire of erythromelalgia?
Symptom relief OngoingErythromelalgia is a rare disorder characterized by red, warm, and painful extremities, which is often precipitated by warm conditions. The pathophysiology is incompletely understood. The management of pain in erythromelalgia is challenging as no single therapy has been found to …
Sponsor: St. Olavs Hospital • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
New home program aims to boost fitness and function after spinal cord injury
Symptom relief CompletedThe proposed phase 2 trial a randomized, placebo-controlled, parallel group trial in persons with cervical or thoracic SCI, AIS grade A, B, C, or D, 6 months or later after injury. The trial will test the hypothesis that a Home-Based Multimodality Functional Recovery and Metaboli…
Phase 2 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Could a smartphone app close the gap in cervical cancer Follow-Up?
Knowledge-focused CompletedIn this study, the researchers will utilize information gained from patient interviews about their knowledge of the cervical cancer screening and treatment process, and perceived barriers surrounding appropriate follow up, to create content for the intervention.
Sponsor: Weill Medical College of Cornell University • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Could an epilepsy drug sharpen memory in Alzheimer's? small trial explores brain calming
Symptom relief CompletedThe aim of this study is to explore the relationship between cortical hyperexcitability, abnormalities of brain network function, and cognitive dysfunction in human patients with AD and whether administration of the antiepileptic medication levetiracetam (LEV) normalizes these me…
Phase 2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC